ReWalk Personal Device Postmarket Study

This study will monitor and further describe the long-term safety of the ReWalk Personal
Device for Subjects and their Companions in institutional and non-institutional
environments, such as the clinic, home, and community. The study will also evaluate the
adequacy of the Multi-Tiered Training Program of the ReWalk Personal Device for Subjects,
their Companions, and their Clinical Trainers, monitor and further describe all ReWalk
Personal Device malfunctions and screen for potential Unexpected Adverse Events.

Inclusion Criteria:

- For use in institutional and non-institutional environments: Subjects with spinal
cord injury at levels T7 to L5.

- Age ≥ 18 years old;

- Hands and shoulders can support crutches or a walker;

- Healthy bone density;

- Skeleton does not suffer from any fractures;

- Able to stand using a device such as EasyStand;

- In general good health;

- Height is between 160 cm and 190 cm (5'3" - 6'2");

- Weight does not exceed 100 kg (220 lbs);

- Proficiency in spoken and written English language.

Exclusion Criteria:

- History of severe neurological injuries or disease other than SCI (MS, CP, ALS, TBI,
etc.);

- Severe concurrent medical disease, including infections, circulatory, heart or lung,
pressure sores;

- Severe spasticity (Ashworth 4)

- Uncontrolled clonus;

- Unstable spine or unhealed limbs or pelvic fractures;

- Heterotopic ossification;

- Significant contractures;

- Psychiatric or cognitive situations that may interfere with proper operation of the
device or participation in this study;

- Pregnancy